- JP-listed companies
- GNI Group Ltd.
- Financials
- Gross profit
GNI Group Ltd. (2160)
Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
| Period End | Gross profit (Million JPY) | YoY (%) |
|---|---|---|
| Dec 31, 2025 | 19,993 | +10.84% |
| Dec 31, 2024 | 18,037 | -19.59% |
| Dec 31, 2023 | 22,431 | +52.13% |
| Dec 31, 2022 | 14,745 | +32.96% |
| Dec 31, 2021 | 11,090 | +34.78% |
| Dec 31, 2020 | 8,228 | +28.66% |
| Dec 31, 2019 | 6,395 | +246436.43% |
| Dec 31, 2018 | 3 | -39.02% |
| Dec 31, 2017 | 4 | +47.25% |
| Dec 31, 2016 | 3 | -17.83% |
| Dec 31, 2015 | 4 | -65.77% |
| Dec 31, 2014 | 10 |